Should you buy Albemarle stock now?
No, the technical signal for Albemarle is currently SELL. Albemarle trades at $128.34 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -6.384 with rising momentum (signal: -8.180); RSI is at 38.3 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $187.16 points to 45.8% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Albemarle stock?
The average analyst price target for Albemarle is $187.16. The current price is $128.34, which gives an upside of 45.8%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $168.44 and $205.88.
Is Albemarle a dividend stock?
Yes, Albemarle is a dividend stock with a dividend yield of 1.36%. The latest dividend was $0.41 per share. The latest ex-dividend date (traded without the dividend) was 6/12/2026. The payout ratio is 72.7%, which is considered moderate. The next dividend payment is scheduled for 10/1/2026.
When does Albemarle pay a dividend in 2026?
Albemarle pays its next dividend on 10/1/2026. The latest dividend was $0.41 per share with an ex-dividend date of 6/12/2026. The dividend yield is 1.36%. The payout ratio of 72.7% points to moderate dividend coverage.
What is the risk of Albemarle stock?
Albemarle is rated as a stock with high risk. the annual standard deviation is 59.5%, which classifies the stock as high risk.
Is Albemarle overvalued?
No, Albemarle is considered undervalued based on the analyst price target (45.8% upside). Albemarle has the following valuation ratios: a P/S ratio of 2.6, a P/B ratio of 1.8. The analyst price target suggests that the stock is undervalued by 45.8%.
Is Albemarle overbought?
No, Albemarle is not overbought. RSI is at 38.3 (neutral zone). The technical indicators show: RSI is at 38.3 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 7.1% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Albemarle earnings report?
The date of the next earnings report for Albemarle has not been published yet. Check the company's investor calendar for updates.
Is Albemarle shorted?
Albemarle has minimal short interest of 0.07% of the free float, which is insignificant and points to very limited bearish sentiment.
Are insiders buying Albemarle stock?
No, insiders are not buying Albemarle shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 2 sales. On a net basis, 876,074 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 11,867,043 $ sold. Active sellers include Cramer Ralf Hans, Masters J Kent, J Kent Masters and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Albemarle a good stock?
Based on our total score, Albemarle is rated as a poor stock with a total score of 29 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 35/100, Quality: 37/100, Momentum: 14/100. In addition: analysts see 45.8% upside to the price target; a dividend of 1.36%; technical signal: Strong Sell. Whether Albemarle is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Albemarle stock?
The outlook for Albemarle based on current data: the average analyst price target is $187.16 (+45.8%); the stock is in a downtrend (below SMA50 and SMA200). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Albemarle stock rising?
Albemarle is rising right now. The technical indicators show: the price is 7.1% above the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Albemarle go?
The average analyst price target for Albemarle is $187.16, which corresponds to a potential gain of 45.8% from the current price of $128.34. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Albemarle fall?
We lack enough history to give a specific floor for Albemarle. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Albemarle do?
Albemarle Corporation laver specialkemikalier og driver en stor forretning globalt. De tjener hovedsageligt penge på tre områder: Lithium, Brom og Katalysatorer.
Især Lithium-segmentet er vigtigt, da de sælger forbindelser som lithiumcarbonat og lithiumhydroxid, der bruges i ... The company belongs to the Materialer sector, more specifically the Specialkemi industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Albemarle as an investment.
Did Albemarle raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Albemarle. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Albemarle making money or losing money?
No, Albemarle is currently not making money — the company is losing money with a negative profit margin of -4.2%, a small loss. That means the business loses money on every dollar of revenue. The operating margin, however, is positive at 24.8% — the core business makes money; the loss comes from financing costs, taxes or one-off items. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Albemarle go bankrupt?
The bankruptcy risk of Albemarle is rated as low. Altman Z2 (a model for assessing financial distress) is 3.97 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 64% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Albemarle have a lot of debt?
No, Albemarle has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 64%. For the materialer sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
